Aktiesnakken — Juli 2012
-
Mon ikke den positive stemning omkring Rockwool fortsætter? http://npinvestor.dk/nyheder/avis-rockwool-vil-have-del-af-kinas-byggeboom-247518.aspx
-
kan de blive ved med at finde flere penge? http://epn.dk/tema/krakamagerbank/article4741115.ece
-
Zealand Pharma (Buy)
Bristol-Myers Squibb (BMS) and AstraZeneca have teamed up to acquire Amylin for USD5.3bn. We believe this should remove the immediate market concerns about Sanofi’s continued commitment to Lyxumia. We expect the Zealand share price to rebound quite significantly following this. We maintain our Buy recommendation and DKK120 per share 12-month target price. -
-
-
@amager. Så havde N.E. Nielsen måske ret
-
bob diamond er også gået kan jeg se. Godt at det har noget konsekvens
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind